Multi-omic analysis in WM: progress being made and challenges that remain
Zachary Hunter, PhD, Dana-Farber Cancer Institute, Boston, MA, discusses the significance of multi-omic analysis in understanding Waldenström's macroglobulinemia (WM), highlighting both the progress made and the challenges with this technique. He emphasizes how ongoing research is beginning to unveil the complexities of the disease's evolution and potential therapeutic opportunities. This interview took place at the 12th International Workshop on Waldenström's Macroglobulinemia (IWWM-12) in Prague, Czech Republic.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.